Chang-Fang Chiu

机构：National Taiwan University, China Medical University, Hospital de Câncer de Barretos, China Medical University Hospital

发表论文 78 篇 · 总被引 3070 次 · h-index 29

代表论文

• Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer (2022 · Annals of Oncology · 被引 463)
• Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study (2025 · The Lancet · 被引 270)
• Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents–A drug repurposing strategy (2016 · Scientific Reports · 被引 90)
• A triterpenoid from wild bitter gourd inhibits breast cancer cells (2016 · Scientific Reports · 被引 60)
• Fenofibrate Suppresses Oral Tumorigenesis via Reprogramming Metabolic Processes: Potential Drug Repurposing for Oral Cancer (2016 · International Journal of Biological Sciences · 被引 51)
• FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism (2017 · Scientific Reports · 被引 40)